Diabetes (T2D) in Adults with CV risks
Research Study
Eligibility
You may be eligible to participate in a clinical research study for a Type 2 Diabetes (T2D) treatment that is currently recruiting volunteers in your area. Keep reading to learn more about this trial…
Study Benefits
- No cost for study related treatment
- Qualified patients may be reimbursed for time & travel
- No insurance is required to participate
If you are…
- Age 18 or older
- Have a diagnosis of T2D with A1C ≥7.0% and ≤10.5%
- Are currently on stable treatment of 1 to 3 oral antihyperglycemic medicines
- Have an elevated risk of cardiovascular event
Find Out If You May Qualify
Please fill out the form and questionnaire to receive more information about the study. You may be contacted by a study team member*
*You may receive a phone call from one of our offices with either an 812 or 270 area code. Please accept this call to discuss the trial. By filling out the form above, you agree to receive phone calls and/or emails about studies near you. You can unsubscribe from our contact list at any time.
Fill out and submit the form above.
– OR –
Contact our research staff.
Se Habla Español
About the Study
The goal of this study is to compare the effect of the investigational medicine with insulin glargine on the occurrence of major adverse cardiovascular events in individuals with type 2 diabetes and overweight or obesity who are at increased risk of a cardiovascular (CV) event. The study will also compare the effects of the investigational medicine and insulin glargine on glycemic control, body weight parameters, and overall safety profile in individuals with T2D and overweight or obesity at increased risk. Your participation in this study will increase the knowledge and understanding of type 2 diabetes in patients with overweight or obesity. This is a placebo controlled, event driven study with a participation timeline expected to be approximately 4 years.
